| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | extracellular matrix | THSD4 PRSS3 COMP CD248 LAMA3 ADAM10 SNED1 SSC5D ELFN1 SPON2 NCAN ADAMTS17 CTSB | 1.05e-05 | 656 | 97 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 PRSS3 COMP CD248 LAMA3 ADAM10 SNED1 SSC5D ELFN1 SPON2 NCAN ADAMTS17 CTSB | 1.09e-05 | 658 | 97 | 13 | GO:0030312 |
| HumanPheno | Absent outer dynein arms | 2.66e-05 | 15 | 21 | 3 | HP:0012256 | |
| HumanPheno | Absent/shortened dynein arms | 3.96e-05 | 17 | 21 | 3 | HP:0200106 | |
| HumanPheno | Dynein arm defect of respiratory motile cilia | 5.61e-05 | 19 | 21 | 3 | HP:0012255 | |
| HumanPheno | Recurrent mycobacterial infections | 1.02e-04 | 62 | 21 | 4 | HP:0011274 | |
| HumanPheno | Abnormal respiratory epithelium morphology | 1.85e-04 | 28 | 21 | 3 | HP:0012253 | |
| HumanPheno | Abnormal respiratory motile cilium morphology | 1.85e-04 | 28 | 21 | 3 | HP:0005938 | |
| HumanPheno | Airway obstruction | 1.88e-04 | 137 | 21 | 5 | HP:0006536 | |
| HumanPheno | Recurrent bacterial infections | 2.16e-04 | 225 | 21 | 6 | HP:0002718 | |
| HumanPheno | Atelectasis | 2.76e-04 | 80 | 21 | 4 | HP:0100750 | |
| Domain | EGF | 2.64e-05 | 235 | 95 | 8 | SM00181 | |
| Domain | EGF_CA | 3.71e-05 | 122 | 95 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 4.07e-05 | 124 | 95 | 6 | IPR001881 | |
| Domain | EGF_Ca-bd_CS | 1.36e-04 | 97 | 95 | 5 | IPR018097 | |
| Domain | Growth_fac_rcpt_ | 1.45e-04 | 156 | 95 | 6 | IPR009030 | |
| Domain | EGF_CA | 1.50e-04 | 99 | 95 | 5 | PS01187 | |
| Domain | NEUZ | 2.53e-04 | 5 | 95 | 2 | SM00588 | |
| Domain | NHR | 2.53e-04 | 5 | 95 | 2 | PS51065 | |
| Domain | Neuralized | 2.53e-04 | 5 | 95 | 2 | PF07177 | |
| Domain | NHR_dom | 2.53e-04 | 5 | 95 | 2 | IPR006573 | |
| Domain | EGF-like_dom | 2.81e-04 | 249 | 95 | 7 | IPR000742 | |
| Domain | TSP_1 | 2.97e-04 | 63 | 95 | 4 | PF00090 | |
| Domain | EGF_1 | 3.24e-04 | 255 | 95 | 7 | PS00022 | |
| Domain | TSP1 | 3.35e-04 | 65 | 95 | 4 | SM00209 | |
| Domain | TSP1_rpt | 3.35e-04 | 65 | 95 | 4 | IPR000884 | |
| Domain | TSP1 | 3.35e-04 | 65 | 95 | 4 | PS50092 | |
| Domain | EGF-like_CS | 3.73e-04 | 261 | 95 | 7 | IPR013032 | |
| Domain | HELP | 3.79e-04 | 6 | 95 | 2 | PF03451 | |
| Domain | HELP | 3.79e-04 | 6 | 95 | 2 | IPR005108 | |
| Domain | EGF_2 | 4.08e-04 | 265 | 95 | 7 | PS01186 | |
| Domain | EGF | 4.60e-04 | 126 | 95 | 5 | PF00008 | |
| Domain | GoLoco_motif | 5.29e-04 | 7 | 95 | 2 | IPR003109 | |
| Domain | GoLoco | 5.29e-04 | 7 | 95 | 2 | SM00390 | |
| Domain | GoLoco | 5.29e-04 | 7 | 95 | 2 | PF02188 | |
| Domain | GOLOCO | 5.29e-04 | 7 | 95 | 2 | PS50877 | |
| Domain | EGF_3 | 1.27e-03 | 235 | 95 | 6 | PS50026 | |
| Domain | WD40_repeat_CS | 1.51e-03 | 164 | 95 | 5 | IPR019775 | |
| Domain | - | 1.55e-03 | 333 | 95 | 7 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.61e-03 | 335 | 95 | 7 | IPR015943 | |
| Domain | CRAL-bd_toc_tran | 1.63e-03 | 12 | 95 | 2 | IPR001071 | |
| Domain | CRAL_TRIO_N | 1.63e-03 | 12 | 95 | 2 | SM01100 | |
| Domain | LINK | 1.93e-03 | 13 | 95 | 2 | SM00445 | |
| Domain | Link_dom | 1.93e-03 | 13 | 95 | 2 | IPR000538 | |
| Domain | Xlink | 1.93e-03 | 13 | 95 | 2 | PF00193 | |
| Domain | LINK_1 | 1.93e-03 | 13 | 95 | 2 | PS01241 | |
| Domain | LINK_2 | 1.93e-03 | 13 | 95 | 2 | PS50963 | |
| Domain | WD40 | 2.08e-03 | 259 | 95 | 6 | PF00400 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.10e-03 | 106 | 95 | 4 | IPR000152 | |
| Domain | PLAC | 2.24e-03 | 14 | 95 | 2 | PF08686 | |
| Domain | WD40 | 2.47e-03 | 268 | 95 | 6 | SM00320 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.48e-03 | 53 | 95 | 3 | IPR011047 | |
| Domain | CRAL/TRIO_N_dom | 2.57e-03 | 15 | 95 | 2 | IPR011074 | |
| Domain | WD40_repeat | 2.66e-03 | 272 | 95 | 6 | IPR001680 | |
| Domain | SUSHI | 2.91e-03 | 56 | 95 | 3 | PS50923 | |
| Domain | WD_REPEATS_1 | 2.96e-03 | 278 | 95 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.02e-03 | 279 | 95 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.02e-03 | 279 | 95 | 6 | PS50294 | |
| Domain | Sushi_SCR_CCP_dom | 3.06e-03 | 57 | 95 | 3 | IPR000436 | |
| Domain | WD40_repeat_dom | 4.09e-03 | 297 | 95 | 6 | IPR017986 | |
| Domain | GOLD_dom | 4.14e-03 | 19 | 95 | 2 | IPR009038 | |
| Domain | PLAC | 4.14e-03 | 19 | 95 | 2 | PS50900 | |
| Domain | PRAME_family | 4.14e-03 | 19 | 95 | 2 | IPR026271 | |
| Domain | PLAC | 4.14e-03 | 19 | 95 | 2 | IPR010909 | |
| Domain | GOLD | 4.14e-03 | 19 | 95 | 2 | PS50866 | |
| Domain | Apc4_WD40_dom | 4.58e-03 | 20 | 95 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.58e-03 | 20 | 95 | 2 | PF12894 | |
| Domain | SRCR | 5.05e-03 | 21 | 95 | 2 | PF00530 | |
| Domain | CRAL_TRIO | 5.05e-03 | 21 | 95 | 2 | PF00650 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.78e-05 | 300 | 62 | 8 | M610 | |
| Pubmed | Pih1d3 is required for cytoplasmic preassembly of axonemal dynein in mouse sperm. | 3.63e-06 | 11 | 99 | 3 | 24421334 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 11832491 | ||
| Pubmed | Nardilysin, ADAM10, and Alzheimer's disease: of mice and men. | 8.02e-06 | 2 | 99 | 2 | 24099785 | |
| Pubmed | Multiple PDZ domain protein maintains patterning of the apical cytoskeleton in sensory hair cells. | 2.40e-05 | 3 | 99 | 2 | 34228789 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25605924 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 19923370 | ||
| Pubmed | Molecular cloning and characterization of cDNA for eukaryotic transcription factor S-II. | 4.79e-05 | 4 | 99 | 2 | 3346229 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 17077281 | ||
| Pubmed | Assembled DJ beta complexes influence TCR beta chain selection and peripheral V beta repertoire. | 4.79e-05 | 4 | 99 | 2 | 19380806 | |
| Pubmed | Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases. | 4.79e-05 | 4 | 99 | 2 | 18355445 | |
| Pubmed | 4.79e-05 | 4 | 99 | 2 | 12925752 | ||
| Pubmed | Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins. | 4.79e-05 | 4 | 99 | 2 | 15537540 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 7.97e-05 | 248 | 99 | 6 | 24006456 | |
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 20383322 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 12782676 | ||
| Pubmed | 7.98e-05 | 5 | 99 | 2 | 13943454 | ||
| Pubmed | A HeLa-cell-encoded p21 is homologous to transcription elongation factor SII. | 7.98e-05 | 5 | 99 | 2 | 8206389 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 26987813 | ||
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 37017303 | ||
| Pubmed | Two forms of human Inscuteable-related protein that links Par3 to the Pins homologues LGN and AGS3. | 1.19e-04 | 6 | 99 | 2 | 16458856 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 26943237 | ||
| Pubmed | Sequence and evolution of the human T-cell antigen receptor beta-chain genes. | 1.19e-04 | 6 | 99 | 2 | 3860845 | |
| Pubmed | 1.19e-04 | 6 | 99 | 2 | 22074847 | ||
| Pubmed | 2.04e-04 | 101 | 99 | 4 | 10997877 | ||
| Pubmed | Novel Cul3 binding proteins function to remodel E3 ligase complexes. | 2.05e-04 | 40 | 99 | 3 | 25011449 | |
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 25446841 | ||
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 18084280 | ||
| Pubmed | 2.22e-04 | 8 | 99 | 2 | 23251662 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | ADGRB2 ADAM10 ICAM5 WDR90 SPIDR CTSB FBXO21 NEURL4 ABCC10 TEDC1 | 3.11e-04 | 925 | 99 | 10 | 28986522 |
| Pubmed | 3.56e-04 | 10 | 99 | 2 | 26755700 | ||
| Pubmed | 3.73e-04 | 613 | 99 | 8 | 22268729 | ||
| Pubmed | 4.34e-04 | 11 | 99 | 2 | 28262416 | ||
| Pubmed | A null allele of Dnaaf2 displays embryonic lethality and mimics human ciliary dyskinesia. | 5.20e-04 | 12 | 99 | 2 | 31107948 | |
| Pubmed | 5.33e-04 | 130 | 99 | 4 | 12421765 | ||
| Pubmed | 6.13e-04 | 13 | 99 | 2 | 22940098 | ||
| Pubmed | 6.13e-04 | 13 | 99 | 2 | 36179691 | ||
| Pubmed | 7.14e-04 | 14 | 99 | 2 | 22653443 | ||
| Pubmed | Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | 9.38e-04 | 16 | 99 | 2 | 35307651 | |
| Pubmed | MicroRNA-140 plays dual roles in both cartilage development and homeostasis. | 1.06e-03 | 17 | 99 | 2 | 20466812 | |
| Pubmed | 1.06e-03 | 17 | 99 | 2 | 21897333 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 1.06e-03 | 17 | 99 | 2 | 23565261 | |
| Pubmed | 1.06e-03 | 17 | 99 | 2 | 37781892 | ||
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 1.16e-03 | 72 | 99 | 3 | 25917818 | |
| Pubmed | 1.19e-03 | 18 | 99 | 2 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 1.19e-03 | 18 | 99 | 2 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 1.19e-03 | 18 | 99 | 2 | 29731491 | |
| Pubmed | 1.19e-03 | 18 | 99 | 2 | 14675769 | ||
| Pubmed | Effect of expression alteration in flanking genes on phenotypes of St8sia2-deficient mice. | 1.19e-03 | 18 | 99 | 2 | 31541165 | |
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.19e-03 | 18 | 99 | 2 | 39181896 | |
| Pubmed | 1.30e-03 | 75 | 99 | 3 | 20637190 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.33e-03 | 19 | 99 | 2 | 28604677 | |
| Pubmed | 1.33e-03 | 19 | 99 | 2 | 21572392 | ||
| Pubmed | Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. | 1.33e-03 | 19 | 99 | 2 | 30760929 | |
| Pubmed | 1.34e-03 | 284 | 99 | 5 | 15057824 | ||
| Pubmed | 1.35e-03 | 167 | 99 | 4 | 22159717 | ||
| Pubmed | 1.47e-03 | 20 | 99 | 2 | 26694250 | ||
| Pubmed | 1.47e-03 | 20 | 99 | 2 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.47e-03 | 20 | 99 | 2 | 21425410 | |
| Pubmed | 1.47e-03 | 20 | 99 | 2 | 24265449 | ||
| Pubmed | 1.51e-03 | 172 | 99 | 4 | 27375898 | ||
| Pubmed | 1.61e-03 | 175 | 99 | 4 | 28071719 | ||
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 1.76e-03 | 302 | 99 | 5 | 30561431 | |
| Pubmed | 1.79e-03 | 22 | 99 | 2 | 31729367 | ||
| Pubmed | 1.79e-03 | 22 | 99 | 2 | 25147951 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 1.87e-03 | 974 | 99 | 9 | 28675297 | |
| Pubmed | The antiobesity factor WDTC1 suppresses adipogenesis via the CRL4WDTC1 E3 ligase. | 1.91e-03 | 453 | 99 | 6 | 27113764 | |
| Pubmed | 1.95e-03 | 23 | 99 | 2 | 19480014 | ||
| Pubmed | Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. | 2.13e-03 | 24 | 99 | 2 | 20705733 | |
| Pubmed | 2.13e-03 | 24 | 99 | 2 | 20448286 | ||
| Pubmed | 2.31e-03 | 25 | 99 | 2 | 37451217 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 2.31e-03 | 25 | 99 | 2 | 12620990 | |
| Pubmed | Peroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia. | 2.31e-03 | 25 | 99 | 2 | 35681537 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 2.49e-03 | 26 | 99 | 2 | 18500982 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 2.49e-03 | 26 | 99 | 2 | 34189436 | |
| Pubmed | 2.61e-03 | 650 | 99 | 7 | 38777146 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q26 | 8.80e-05 | 206 | 99 | 5 | chr15q26 | |
| Cytoband | 15q26 | 5.42e-04 | 16 | 99 | 2 | 15q26 | |
| Cytoband | 15q24 | 9.41e-04 | 21 | 99 | 2 | 15q24 | |
| Cytoband | 8q24 | 1.68e-03 | 28 | 99 | 2 | 8q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.73e-03 | 797 | 99 | 7 | chr19p13 | |
| GeneFamily | SEC14 family|PRELI domain containing | 1.78e-04 | 6 | 63 | 2 | 1063 | |
| GeneFamily | WD repeat domain containing | 2.98e-04 | 262 | 63 | 6 | 362 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-06 | 175 | 99 | 6 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-06 | 175 | 99 | 6 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-06 | 181 | 99 | 6 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 5.07e-06 | 196 | 99 | 6 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.53e-06 | 199 | 99 | 6 | bd66a8d1a7cc92313328acc7c7ae0442faff951e | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-gd_T|Influenza_Severe / Disease, condition lineage and cell class | 5.53e-06 | 199 | 99 | 6 | b1ecc8aa5a98fe42d678ab07b310d62ebaacdecf | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.15e-05 | 132 | 99 | 5 | 893b7ec2a2d8a140cc98575d1beca1189f053e9a | |
| ToppCell | Control-NK|World / Disease group and Cell class | 1.70e-05 | 143 | 99 | 5 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 2.51e-05 | 155 | 99 | 5 | 72c61be0a8d3ee10600a33c58fb01c35fd3f14d4 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 159 | 99 | 5 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 159 | 99 | 5 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | Healthy_Control-Lymphoid-T-innate_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.38e-05 | 165 | 99 | 5 | 1ade67229b50fe20eb392262a3e1ee4306b73290 | |
| ToppCell | -SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.48e-05 | 166 | 99 | 5 | bc9323de1373fdc0357e6bb46874f6c4787443a9 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 168 | 99 | 5 | 19d2c763b50e7168dfa7449fc407489b055526c2 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-mature_NK_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 168 | 99 | 5 | fa198bd53b2d640d9a8684783bf5ca23314caae2 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class | 3.79e-05 | 169 | 99 | 5 | 8c8168ac93a808d7b4756e4491db2b2979df1c1f | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 3.79e-05 | 169 | 99 | 5 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 3.90e-05 | 170 | 99 | 5 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 171 | 99 | 5 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | Healthy_donor-MAIT|World / disease group, cell group and cell class (v2) | 4.12e-05 | 172 | 99 | 5 | 6524eb2be1c78700ad367e62624a4d7eb48b54f0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 99 | 5 | 7c5e4809205ce1a0a301c15442af00a2e2b9b301 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 175 | 99 | 5 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-05 | 175 | 99 | 5 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.47e-05 | 175 | 99 | 5 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.47e-05 | 175 | 99 | 5 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | COVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class | 4.72e-05 | 177 | 99 | 5 | 34e9455790bae905dd91923792f4109d18b7686e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-05 | 178 | 99 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.85e-05 | 178 | 99 | 5 | 31c847d7f7aa0f6d820afbb45d507992f5e9dc2f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.98e-05 | 179 | 99 | 5 | 327cc39161741ddbc4e8d45b9b3d30b3ce508929 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.25e-05 | 181 | 99 | 5 | 58f76bb9ea1518c2b629a0256a3f6595a9278152 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 5.39e-05 | 182 | 99 | 5 | 6e35892fa959ee31591850ded8f1088195ddeb01 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.53e-05 | 183 | 99 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 5.68e-05 | 184 | 99 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.82e-05 | 185 | 99 | 5 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-05 | 185 | 99 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-05 | 185 | 99 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.82e-05 | 185 | 99 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.98e-05 | 186 | 99 | 5 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.98e-05 | 186 | 99 | 5 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.13e-05 | 187 | 99 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Myeloid-Monocytes|Control / group, cell type (main and fine annotations) | 6.44e-05 | 189 | 99 | 5 | 3335d16bd0ffa0c1ddd06d7da645299148130c3f | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B_plasma|bone_marrow / Manually curated celltypes from each tissue | 6.44e-05 | 189 | 99 | 5 | dceb011216deb4ffd830144a53c635c05dff5ec5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.61e-05 | 190 | 99 | 5 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.77e-05 | 191 | 99 | 5 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 192 | 99 | 5 | 0b9b2eaed45456d7d74ce78a64ef4a26ac2458fb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-05 | 192 | 99 | 5 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.11e-05 | 193 | 99 | 5 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.11e-05 | 193 | 99 | 5 | 4fb020f11fd7aff06952bfeaabc79b2c7b8873f6 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.29e-05 | 194 | 99 | 5 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.29e-05 | 194 | 99 | 5 | 885355ebe98e974f841cc59dce3b5228c642c5d0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.29e-05 | 194 | 99 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.47e-05 | 195 | 99 | 5 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 7.47e-05 | 195 | 99 | 5 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.65e-05 | 196 | 99 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|mLN / Region, Cell class and subclass | 7.65e-05 | 196 | 99 | 5 | 03b79f237e4f7ebab46b277d05377569c6342cf7 | |
| ToppCell | mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma|mLN / shred on region, Cell_type, and subtype | 7.65e-05 | 196 | 99 | 5 | e8b12b046d42a58e6f4d9419ab05a5c55e764f34 | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 7.65e-05 | 196 | 99 | 5 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 196 | 99 | 5 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.84e-05 | 197 | 99 | 5 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.84e-05 | 197 | 99 | 5 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.84e-05 | 197 | 99 | 5 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.84e-05 | 197 | 99 | 5 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.84e-05 | 197 | 99 | 5 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.84e-05 | 197 | 99 | 5 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 7.84e-05 | 197 | 99 | 5 | bd1d01d6c49f68f5c85d84df96c90dd04b9de09b | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|World / disease group, cell group and cell class | 7.84e-05 | 197 | 99 | 5 | 60fee75b12451206bb2c07b61651a73c59ec6ade | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.03e-05 | 198 | 99 | 5 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.03e-05 | 198 | 99 | 5 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 198 | 99 | 5 | 110f7ebb3e1ec19508d4d2b973e1f64e7bdbb5b5 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.03e-05 | 198 | 99 | 5 | ecf1cb56bdd43b9c62cec3fcf914ede608a7c8a0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.03e-05 | 198 | 99 | 5 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma|Caecum / shred on region, Cell_type, and subtype | 8.03e-05 | 198 | 99 | 5 | 3893fcfc1de5937be3ccc7e545f711f2c95a2827 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|Caecum / Region, Cell class and subclass | 8.03e-05 | 198 | 99 | 5 | d8cb78b1763710a158cf22b59aebaa44afd2374c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-05 | 198 | 99 | 5 | b19a089eb80af3428891f2ff00e53a6e11894fa3 | |
| ToppCell | severe-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.22e-05 | 199 | 99 | 5 | 6ee4c2e6049860071169366b7e662d5c1a3cc54b | |
| ToppCell | healthy_donor-Myeloid|healthy_donor / Disease condition, Lineage, Cell class and subclass | 8.22e-05 | 199 | 99 | 5 | d41994e08f7c3f5bd865b689db8f032efbe88d24 | |
| ToppCell | COVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | 621af09aae34226902c03edf556562f3ab35a7d8 | |
| ToppCell | mLN-(1)_T_cell-(10)_CD8_T|mLN / shred on region, Cell_type, and subtype | 8.41e-05 | 200 | 99 | 5 | 6f02ba3a76e8aa3083efea9cb4ee587799c61fda | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 36de49593cf6ff1c9229fcceb150c1d68658a360 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.41e-05 | 200 | 99 | 5 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 200 | 99 | 5 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.41e-05 | 200 | 99 | 5 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.41e-05 | 200 | 99 | 5 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | e57452b73abb21cb3f645d45523ab93f6bef0243 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.41e-05 | 200 | 99 | 5 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | c4e08cf539c12bb7c61be6d44b4f074bb460f526 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.41e-05 | 200 | 99 | 5 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | COVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | b0a5bee87700ce38f26f95a6f491da7e27cade51 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 200 | 99 | 5 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | COVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | a40768e8e58c86b8e20bc188b9274ebe412fc765 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2-SERPINF1-L2-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | f922f9f223cbfed71b8e3115b16b51dc4d7b66b8 | |
| ToppCell | mLN-T_cell-CD8_T|mLN / Region, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | a221213f9245297a5d6196564c1043f8c17eb857 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.41e-05 | 200 | 99 | 5 | 4243a9d32f3a11141284d0d944cb81194b532876 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 4c3c11dd5e71ebc3d62264eeaeb71a850b149779 | |
| ToppCell | (10)_CD8_T|World / shred on Cell_type and subtype | 9.45e-05 | 205 | 99 | 5 | 87c36989d0fc926f36d6b911ede068455f027177 | |
| ToppCell | Mild-Myeloid-Macrophages-|Mild / Condition, Lineage, Cell class and cell subclass | 1.59e-04 | 122 | 99 | 4 | b837456a6a236add2c0005cb3ca71568d631014e | |
| ToppCell | Entopeduncular-Macroglia-ASTROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.97e-04 | 129 | 99 | 4 | c37bdd6c0b2944fbfa064922954ea0e263160e2a | |
| Disease | Primary Ciliary Dyskinesia | 4.88e-04 | 47 | 96 | 3 | C4551720 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.73e-03 | 19 | 96 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | epiandrosterone sulfate measurement | 2.99e-03 | 25 | 96 | 2 | EFO_0021120 | |
| Disease | intestinal permeability measurement | 3.24e-03 | 26 | 96 | 2 | EFO_0011031 | |
| Disease | brain cancer (implicated_via_orthology) | 3.24e-03 | 26 | 96 | 2 | DOID:1319 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCRWSEECGRAAGRA | 201 | O60241 | |
| AGGLARADCWLIEGD | 21 | P0C7U0 | |
| GSCWAFGAVEAISDR | 106 | P07858 | |
| RDFDDGVLGLAWVGA | 321 | O14672 | |
| EAWRACRELGGDLAT | 46 | Q9HCU0 | |
| ADGCFLGDVGFWVER | 6 | Q8WXK3 | |
| ERDGSRSCVCAVGWA | 246 | P49747 | |
| VACWLLGAGAEADFS | 26 | Q5VU97 | |
| VLACGLSRIWGEERG | 16 | P24530 | |
| DRFRDCGSSGWLGLN | 596 | Q9Y4B4 | |
| LRGGDVWLDSCRFAD | 796 | Q8WUJ3 | |
| LDGTECGADKWCRAG | 516 | Q8TE56 | |
| GAAWLDRELGGCELA | 1176 | Q8TDY8 | |
| ASGAAGRCKDAWASE | 66 | A6NED2 | |
| GALWDSRAAEAVCRA | 71 | P30203 | |
| RWCQGAEGATLDIFD | 331 | O94952 | |
| GWEQALGARVEACRA | 476 | Q5T3U5 | |
| NDRIGEGRACWSLGN | 316 | P81274 | |
| CADRGASVQWRGLDT | 51 | Q13477 | |
| EAARIWATATCGERG | 56 | Q16787 | |
| RAWEELDGGLGSCQA | 6 | Q96MG2 | |
| GAAWVGVCELSGRDA | 166 | O95872 | |
| WFRGRDVLDLGCNVG | 441 | Q7L2J0 | |
| GSGIAEVCLWEAGDA | 1456 | Q6PRD1 | |
| ELADRVGEGRACWSL | 321 | Q86YR5 | |
| LGECAQDGWDEASVG | 26 | Q6ZP29 | |
| WRAGDLEALGAGSSV | 276 | Q5VZ46 | |
| LAGIISWGEGCAERN | 256 | Q9GZN4 | |
| ADADEWCDSGLGSLG | 11 | Q15653 | |
| GLLLTGWTFDRGACE | 121 | O60486 | |
| WVEGSGRLFSCEVDG | 586 | Q9UMF0 | |
| GLADDSADALWVRAG | 451 | Q9UJ96 | |
| LDGIWAGTRDFVACN | 266 | P54315 | |
| VGRCGSDCGWDRGEA | 296 | Q9HBH9 | |
| VLDSCDGALGWRGLA | 31 | Q9Y616 | |
| ALAGCELAWGVARDT | 146 | O60240 | |
| SGLWRVCFLAGEERG | 56 | Q9UF02 | |
| VAAWGRARATGGDLE | 321 | Q8N9W5 | |
| GADTGGACDSLLWIR | 41 | A6NGS2 | |
| DDTLVVGLAVCWGGR | 1896 | O75417 | |
| DALCLEGGVSARWAR | 16 | Q9NVV2 | |
| GLAARGAEWEARAVE | 106 | A1A5D9 | |
| VCDSAGGGSDLRLWT | 3676 | Q99698 | |
| LDDSIGCAVWFASRG | 456 | Q9NWL6 | |
| RIVGDWTEGLFNACG | 356 | P04839 | |
| KDRACAEAWARGGYA | 286 | Q8NEP3 | |
| DLARVLGWGSACDDD | 411 | Q16760 | |
| ATGGRDGCIRLWDLT | 251 | Q05BV3 | |
| ATGGRDGCIRLWDTD | 251 | Q6ZMW3 | |
| GAWERCAGSAEAEQL | 41 | Q9NYC9 | |
| QGALCWGRFAELGAE | 421 | Q5VWM4 | |
| CVLRWQFASDGGDIG | 301 | Q9UDX3 | |
| CVLRWQFASDGGDIG | 301 | B5MCN3 | |
| AGELRLWVNGRDCGV | 166 | Q96JN8 | |
| AWGASVGGRSCEELT | 16 | Q9H300 | |
| AWGELDAGEAEARAR | 236 | Q6KF10 | |
| ARGCRAAADGSLQWE | 21 | Q96GQ5 | |
| IADGLARACAALGDW | 701 | Q8IYR2 | |
| WFVGVDSLDLCDGDR | 161 | Q9BUD6 | |
| RWGAEGRDVCAANGS | 141 | Q9UIG8 | |
| GLEALEGCWDRGNRA | 511 | Q9BXQ6 | |
| GLWAEGQARCAEEAR | 51 | O15061 | |
| EGVLRSWGDGVAADC | 96 | Q9H7V2 | |
| EGGAEDADWGVAAFC | 621 | Q6ZMQ8 | |
| DWVDGLALRGLADRC | 151 | Q9H469 | |
| DGFDNCDAGWLSDRT | 201 | O14594 | |
| VGEAAAGRGSLEWLD | 591 | Q9P2P6 | |
| GWDLRDAAVACRELG | 226 | A1L4H1 | |
| GSVCDDAWDLRDAAV | 326 | A1L4H1 | |
| GVLFDCDGVLWNGER | 21 | Q96GD0 | |
| WAFRIDDAQVRVGGC | 251 | Q8TER0 | |
| DEWLGRCILDATGVG | 276 | Q8IZ52 | |
| FCLEEDGAAGAGWVR | 36 | Q8NE01 | |
| QGALCWGRFAELGAE | 421 | Q5VXH5 | |
| REEAVSALCWGTGGE | 41 | Q6RFH5 | |
| GRCFLSWEADDGGIG | 1331 | Q96KV7 | |
| EEGAACKDGRLWAGD | 1661 | O75970 | |
| DGEGDDLDLWTVRCS | 136 | Q9HCN8 | |
| AAASLSEAWLRCGEG | 41 | Q14159 | |
| AERRRAAWEAKAGGC | 376 | Q86SX3 | |
| SCGDREWLRAVASVG | 191 | Q9BSE2 | |
| ESGCLGRTGARVWLF | 86 | P56557 | |
| ALWGIETRGRCEDSA | 26 | O43847 | |
| LGDGSCDCDVGWRGV | 1411 | Q8WWQ8 | |
| GRVLDDAWDLRGAGV | 456 | Q4G0T1 | |
| FGAGAGRIWLDELGC | 611 | Q4G0T1 | |
| DEVGCRGSEASLWGC | 851 | Q4G0T1 | |
| IVSAEAWGRADCGFT | 256 | P0DTU4 | |
| VALRVLREESGWCGG | 61 | Q96EH8 | |
| LGGRTWRAARDADGC | 51 | P35030 | |
| WRAARDADGCEALGT | 56 | P35030 | |
| LGDLCDDVSERDWGV | 106 | P17020 | |
| SAEAWGRADCGFTSE | 121 | A0A5B9 | |
| GVQSLEEACWRARGD | 101 | Q9Y2Y4 | |
| GFGGEGCEATLWDLR | 251 | Q8NA23 | |
| EWSERCSAECGAGVR | 801 | Q6ZMP0 | |
| GGAADCSFWERLLAR | 106 | P28074 | |
| NIWGEARVGSELCAG | 1176 | Q12789 | |
| SEENGGAWRILDCGS | 2036 | P01266 | |
| RTEERGAHQGACADW | 116 | Q96PQ6 | |
| LLGSSGRDCERDGWS | 271 | Q9NWH7 | |
| GLCINAGWRCDGDAD | 241 | O75096 | |
| NIDDCWIGGRDASGR | 76 | P17050 |